Dr. David Chaney
Assistant Director for Local Impact | Diabetes UK
Belfast, IRELAND
Expert in Diabetic Care, Chronic Illness, and Patient Education. Appointed as the Assistant Director for Local Impact at Diabetes UK.
Media
Publications:
Documents:
Videos:
Audio/Podcasts:
Biography
Dr David Chaney was appointed as Assistant Director for local Impact at Diabetes UK in April 2017 with responsibility for 8 teams across the UK. Previously David worked as the National Director for Diabetes UK Northern Ireland between July 2015 and April 2017. Prior to this appointment he worked as the Senior Education Specialist at the International Diabetes Federation. Within his role at IDF he was responsible for the delivery diabetes education projects around the world. David has worked as a Lecturer in Nursing at Ulster University, he qualified as a staff nurse in 1992 and has worked within the area of diabetes care since 1994. He was awarded an MSc in Nursing in 2001 and subsequently completed a Postgraduate Diploma in Clinical Health Sciences Education both at Trinity College Dublin. David completed his PhD in 2010 within the area of structured diabetes education for adolescents between the ages of 13 – 19 years. David was awarded the Janet Kinson Named Lecture and Royal College of Nursing Northern Ireland Research Nurse of the Year for his work within education and diabetes.
Areas of Expertise (3)
Patient Education
Diabetes Care
Chronic Illness
Accomplishments (3)
Research Nurse of the Year Northern Ireland, Royal College of Nursing
2012
Registered Nurse Tutor, University of Dublin, Trinity College, Dublin 2
2002
Registered General Nurse (Part 1 of register), Barnet College of Nursing & Midwifery, Barnet, Herts.
1992
Education (5)
University of Ulster: Ph.D., Structured Diabetes Education for Adolescents 2010
University of Hertfordshire: Diploma, Professional Nursing Studies 2007
University of Dublin: Postgraduate Diploma, Clinical Health Sciences Education 2002
University of Dublin: M.S., Nursing Science 2001
University of Dublin: University of Dublin, Nursing Studies 1999
Affiliations (12)
- Chairperson Annual Conference Organising Committee for Diabetes UK, 2014 - 2015
- Chairperson Northern Ireland Diabetes Nurses Specialists Study Group, 2012 - 2014
- Member Science & Research Advisory Committee for Diabetes UK, 2012 - 2013
- Elected Representative for Diabetes UK Northern Ireland, 2009 - 2013
- Member of the Clinical Resource Effectiveness Group for review of Diabetes Service Framework Northern Ireland, Department of Health Northern Ireland, 2012
- Board Member, Cross Border Diabetes Project, Cooperation and working together for health gain and social wellbeing in border areas (CAWT)
- Peer Reviewer, Journal of Patient Education
- Peer Reviewer, Journal of Clinical Nursing
- Peer Reviewer, International Journal of Older People
- Peer Reviewer, Journal of Diabetes Nursing
- Registered General Nurse (Part 1) / Registered Nurse Teacher, Nursing & Midwifery Council
- Full Membership, Royal College of Nursing
Media Appearances (8)
Northern Ireland launches new Footcare Pathway
Diabetes Times online
2020-01-23
Key partner of the Diabetes Network, Dr David Chaney, Assistant Director for Local Impact at Diabetes UK said: “The new Pathway is a welcome step in the prevention of diabetes-related amputations and improvement of access to foot care for people living with the condition in Northern Ireland. Diabetes-related complications, including amputations, can be devastating but they can be prevented with the right treatment and support.
Diabetes in children - here's how to spot the signs
Belfast Live online
2019-06-16
Dr David Chaney, Assistant Director for Local Impact for Diabetes UK, said: "Too many children and young people are not diagnosed with Type 1 diabetes until their lives are at risk.
Lifestyle warning as Northern Ireland diabetes cases up 70% in 12 years
Belfast Telegraph online
2019-04-02
Dr David Chaney, Diabetes UK assistant director for local impact, said: "We only have to look at the startling yearly increase in the number of people being diagnosed with Type 2 diabetes to know that we cannot ignore this very serious condition.
Don't buy expensive 'diabetic' chocolate, warns Diabetes NI Director
Ballymena Times online
2016-12-05
Within his advice, Dr Chaney urged people not to buy expensive ‘diabetic’ chocolate. He said: “If you are one of the 88,000 people in Northern Ireland living with diabetes, following a healthy lifestyle during the festive period can be a struggle, but it shouldn’t mean treats are off the table entirely.
New Diabetes Network for NI
Health and Social Care Board online
2016-11-30
Diabetes UK Northern Ireland National Director, Dr David Chaney, commented: “Diabetes UK Northern Ireland anticipates that the work of the Diabetes Network is outcome-driven in order to plan, provide and importantly, implement changes, for the health care of 100,000 people living with diabetes. We are optimistic that service users will be given a voice throughout the process in order to highlight the issues that matter the most and identify the gaps in service that require action.
15-year-old athlete Ryan determined to overcome diabetes challenges
The Irish News online
2016-06-14
"More and more families are being impacted by the condition, whether type 1 or type 2 diabetes, and we cannot afford to ignore it," Dr David Chaney, director of Diabetes UK in Northern Ireland, says.
Diabetic Hollie hopes she will finally get word that an insulin pump is hers after seven-year wait
Belfast Telegraph online
2016-04-12
Diabetes UK NI national director Dr David Chaney said: "Patients should not have to wait an unreasonable amount of time to access a service that will improve their self-management of Type 1 diabetes and help avoid long-term complications such as blindness or lower limb amputation."
Plans unveiled to ‘transform’ diabetes services in NI
Nursing Times online
2016-03-08
David Chaney, Diabetes UK director for Northern Ireland, welcomed the launch of the framework, which the charity advised on. He said: “This is an important development in addressing the challenges faced by our population and people in Northern Ireland living with diabetes.”
Featured Articles (5)
Sustaining diabetes prevention and care interventions: A multiple case study of translational research projects
Diabetes Research and Clinical Practice
Chaney, D, Garst, J, L'Heveder, R, et al.
2016 Background: This study identifies the barriers and enablers for sustainability of interventions in primary and secondary prevention of diabetes. In the context of translational research, sustainability is defined as the continued use of program components and activities for the continued achievement of desirable program and population outcomes. Methods: In this study, eleven translational research projects, supported by the BRIDGES program of the International Diabetes Federation, were investigated. By theoretically-informed semi-structured interviews and analyses of project reports, qualitative data was collected on the sustainability outcomes and the barriers and enablers. Results: The sustainability outcomes can be grouped in three main areas: (1) sustainability at the intervention site(s); (2) diffusion to the wider community; and (3) replication of the intervention at other site(s). Each of the outcomes has their own set of enablers and barriers, and thus requires consideration for a different sustainability strategy. Conclusions: This study is the first international study that relates the sustainability outcomes of translational research project to specific barriers and enablers, and develops an evidence-based framework which provides practical advice on how to ensure the sustainability of health interventions.
Reasons why patients referred to diabetes education programmes choose not to attend: a systematic review
Diabetic Medicine
Horigan, G, Davies, M, Findlay-White, F, Chaney D, Coates, V
2016 Aims: To identify the reasons why those offered a place on diabetes education programmes declined the opportunity. Background: It is well established that diabetes education is critical to optimum diabetes care; it improves metabolic control, prevents complications, improves quality of life and empowers people to make informed choices to manage their condition. Despite the significant clinical and personal rewards offered by diabetes education, programmes are underused, with a significant proportion of patients choosing not to attend. Methods: A systematic search of the following databases was conducted for the period from 2005-2015: Medline; EMBASE; Scopus; CINAHL; and PsycINFO. Studies that met the inclusion criteria focusing on patient-reported reasons for non-attendance at structured diabetes education were selected. Results: A total of 12 studies spanning quantitative and qualitative methodologies were included. The selected studies were published in Europe, USA, Pakistan, Canada and India, with a total sample size of 2260 people. Two broad categories of non-attender were identified: 1) those who could not attend for logistical, medical or financial reasons (e.g. timing, costs or existing comorbidities) and 2) those who would not attend because they perceived no benefit from doing so, felt they had sufficient knowledge already or had emotional and cultural reasons (e.g. no perceived problem, denial or negative feelings towards education). Diabetes education was declined for many reasons, and the range of expressed reasons was more diverse and complex than anticipated. Conclusion: New and innovative methods of delivering diabetes education are required which address the needs of people with diabetes whilst maintaining quality and efficiency.
Screening for type 2 diabetes and pre-diabetes in general practice: a descriptive study of Maltese practices
Journal of Primary Care Diabetes
Grech M, Chaney D
2014 Objective: The aim of this research study was to ascertain the awareness of Maltese family doctors to the prevalence and significance of impaired glucose regulation and early diagnosis of type 2 diabetes and whether practices were influenced by employment status, post-graduate training in diabetes or years since graduation. Methods: A specially constructed questionnaire was distributed by mail to all the 298 family doctors listed as Specialists in Family Medicine in the Maltese Medical Council register. Participants had to be practising family medicine in Malta. Results were analysed using SPSS 20.0 aiming for a significance criterion of 0.05 and a power of 80%. Results: Valid replies were received from 154 GPs (51.7%). 93.2% claimed to offer their patients some form of screening. Screening levels reached up to 95.9% in the presence of specific risk factors (e.g., high previous HbA1c levels) but fell to between 46.2% and 58.7% in patients over 50, the physically inactive and those who suffer from polycystic ovarian syndrome. Screening using capillary glucose is widespread (70.8%) as opposed to the oral glucose tolerance test (23.4%). Results also show a high use of urinalysis in screening (53.2%) and a paradoxical lack of use of HbA1c in screening by young doctors and by those with recent extra training in diabetes. Conclusions: The need for a structured screening programme in Malta and its viability need to be evaluated by further studies. Educational support to GPs together with logistic support for GPs needs to be improved.
Evaluation of the Effectiveness of a Structured Diabetes Education Programme (CHOICE) on Clinical Outcomes for Adolescents with Type 1 Diabetes: A Randomised Controlled Trial
Journal of Diabetes and Metabolism
Coates V, Chaney D, Bunting B, Shorter GW, Shevlin M, et al.
2013 Aim: To evaluate the impact of the CHOICE structured diabetes education programme for adolescents with Type 1 diabetes on glycossylated haemoglobin, body mass index, episodes of hyper and hypoglycaemia and dietary adherence. Methods: Multi-centred pragmatic randomised controlled trial (ISRCTN 13331558) across seven hospital sites in Northern Ireland, with 24 month follow-up. 135 adolescents between 13 – 19 years with Type 1 diabetes were randomly assigned to structured diabetes education (n = 70) or control (n = 65). The intervention was designed to enable adolescents to adjust diet and insulin regimens, liberating their lifestyle to more closely match that of their peers without diabetes. It consisted of 12 hours education over 4 weeks, in 3 hourly interactive, group based sessions. Clinical outcome measures included glycossylated haemoglobin (HbA1c), body mass index, number of episodes of reported hyperglycaemia and hypoglycaemia and dietary adherence. Data were analysed on an intention to treat basis and was undertaken by a series of tests assessing both within and between group differences in means, variances and covariances. Results: No significant difference between groups in HbA1c was noted despite the dietary liberation of the intervention group at 12 months however, there was a significant difference at 24 months (HbA1c) IG intervention % (mmol/mol) 9.53(81) v 8.99(75) control. There was no difference in BMI or in reported hyper or hypoglycaemic episodes. Conclusion: Structured diabetes education (SDE) facilitated a more flexible diet, to which adolescents could adhere, with no detriment to glycaemic control at 12 m, but not at 24 m post intervention.
Systematic review of descriptive cohort studies on the dynamics of glycaemia among adults admitted to hospital with acute stroke
Journal of Advanced Nursing
Laird, Liz, Coates, Vivien and Chaney, David
2012 Aim: This article presents the results of a systematic review of descriptive cohort studies on the dynamics of glycaemia among adults admitted to hospital with acute stroke. Background: Hyperglycaemia is common among adults admitted to hospital with stroke. Design: Systematic review. Data sources: A search for descriptive cohort studies published between January 1996-June 2011, was conducted in MEDLINE, PubMed and Embase electronic databases. The search was performed using the terms 'stroke', 'hyperglycaemia' and/or 'glucose' combined and limited to adults and English language publications. Searching of citations from identified studies supplemented the electronic searches. Review methods: A systematic review was conducted of eight studies, meeting the criteria of: (1) descriptive cohort studies; (2) adults admitted to hospital with acute stroke; and (3) glycaemic status monitored over at least two consecutive days from admission to hospital. The review adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis standards. Results: The dynamics of glycaemia after stroke has been investigated in seven prospective cohort studies and one retrospective study. The patterns that emerged were persisting normoglycaemia, transient hyperglycaemia, persisting hyperglycaemia and delayed hyperglycaemia. Surges in glycaemia are likely on days 2 and 3 and some adults will not exhibit hyperglycaemia till day 7. Conclusion: Further large cohort studies are required to explore the dynamic of glycaemia after stroke for at least 1 week duration. The timing of formal screening for diabetes mellitus is important, as early screening may overestimate detection rates.
Social